We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EOLS market cap is 933.36M. The company's latest EPS is USD -0.9742 and P/E is -15.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.02M | 61M | 59.33M | 66.91M | 61.09M |
| Operating Income | -11.64M | -13.77M | -7.34M | -9.28M | -13.05M |
| Net Income | -16.92M | -11.83M | -13.11M | -11.35M | -19.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.93M | 58.55M | 99.67M | 148.62M | 202.09M |
| Operating Income | -98.95M | -153.07M | -69.91M | -65.33M | -49.23M |
| Net Income | -90.03M | -163.01M | -46.81M | -74.41M | -61.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 167.97M | 189M | 226.18M | 233.77M | 229.61M |
| Total Liabilities | 187.34M | 209.69M | 207.73M | 214.46M | 223.72M |
| Total Equity | -19.37M | -20.69M | 18.44M | 19.31M | 5.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 240.44M | 209.07M | 257.48M | 177.98M | 189M |
| Total Liabilities | 160.99M | 282.03M | 175.61M | 159.48M | 209.69M |
| Total Equity | 79.46M | -72.96M | 81.88M | 18.5M | -20.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.82M | -34.01M | -10.62M | -17.09M | -22.81M |
| Investing | -1.27M | -1.63M | -797k | -2.05M | -3.46M |
| Financing | 21.12M | 44.64M | 45.66M | 50.14M | 48.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -93.38M | -57.87M | -33.39M | -84.91M | -34.01M |
| Investing | -23.43M | 12.19M | 4.03M | -2.94M | -1.63M |
| Financing | 133.55M | 38.35M | 73.05M | -4.15M | 44.64M |
| Market Cap | 933.36M |
| Price to Earnings Ratio | -15.11 |
| Price to Sales Ratio | 4.61 |
| Price to Cash Ratio | 14.83 |
| Price to Book Ratio | -45.05 |
| Dividend Yield | - |
| Shares Outstanding | 63.32M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | 7.75% |
| 52 Week High | 17.82 |
| 52 Week Low | 9.25 |
| Spread (Intraday) | 0.33 (2.19%) |
| Company Name | Evolus Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.evolus.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
